Zoetis | ZTS - Cash And Equivalent


Zoetis reported $1.48B in Cash and Equivalent for its fiscal quarter ending in June of 2026.





Cash And Equivalent Change Date
AbbVie USD 6.57B 2.82B Jun/2026
Align Technology USD 1.1B 42.76M Jun/2026
Bayer EUR 4.29B 1.44B Jun/2026
Bristol-Myers Squibb USD 8.72B 852M Jun/2026
Charles River Laboratories USD 192.02M 195K Jun/2026
Coherus Biosciences USD 82.92M 32.32M Jun/2026
Dentsply International USD 239M 49M Jun/2026
Eli Lilly USD 8.95B 3.67B Jun/2026
Henry Schein USD 157M 19M Jun/2026
Idexx Laboratories USD 196.93M 3.6M Jun/2026
Illumina USD 1.09B 329M Mar/2026
IQVIA Holdings USD 1.91B 38M Jun/2026
J&J USD 20.42B 1.27B Jun/2026
Laboratory Of America USD 141.8M 839.3M Jun/2026
Merck USD 6.85B 1.52B Jun/2026
Neogen USD 185.5M 25.6M Mar/2026
Pacira USD 205.88M 61.57M Jun/2026
Perrigo USD 357.2M 174.4M Mar/2026
Pfizer USD 976M 727M Jun/2026
Phibro Animal Health USD 61.42M 6.49M Jun/2026
Quest Diagnostics USD 626M 233M Jun/2026
Sanofi EUR 6.35B 806M Jun/2026
Sanofi EUR 5.54B 2.11B Mar/2026
Zoetis USD 1.48B 465M Jun/2026